Document is current
Any future updates will be listed below
-
Authors
Mok, Chi Chiu https://orcid.org/0000-0003-3696-1228
Teng, Y. K. Onno
Saxena, Ramesh https://orcid.org/0000-0001-5722-9509
Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
- License Information
-
More Information
Article History
Accepted: 3 February 2023
First Online: 2 March 2023
Competing interests
: Y.K.O.T. received an unrestricted research grant from GlaxoSmithKline, Aurinia Pharmaceuticals and Vifor Pharma. The Leiden University Medical Center received consulting fees for consultancy provided by Y.K.O.T. from Aurinia Pharmaceuticals, GlaxoSmithKline, KezarBio, Novartis, Otsuka Pharmaceuticals and Vifor Pharma. Y.T. has received speaking fees and/or honoraria from AbbVie, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eli Lilly, Eisai, Gilead, GlaxoSmithKline, Mitsubishi-Tanabe and Pfizer, and has received research grants from AbbVie, Asahi-Kasei, Boehringer-Ingelheim, Chugai, Daiichi-Sankyo, Eisai and Takeda. The remaining authors declare no competing interests.
